CRISPR Therapeutics AG CRSP
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.63% | 37.36% | 31.61% | 3.78% | -1.03% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.99% | -21.40% | -30.01% | -28.33% | 19.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -89.23% | -88.57% | -88.57% | -- | -- |
| Total Current Assets | 18.45% | 36.81% | 31.10% | 2.51% | -0.76% |
|
|
|||||
| Total Current Assets | 18.45% | 36.81% | 31.10% | 2.51% | -0.76% |
| Net Property, Plant & Equipment | -11.19% | -11.01% | -10.70% | -10.80% | -10.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.44% | -13.22% | -67.31% | -34.96% | -64.56% |
| Total Assets | 13.86% | 30.60% | 25.84% | 1.04% | -0.48% |
|
|
|||||
| Total Accounts Payable | 74.49% | 15.93% | 4.46% | -24.28% | -24.26% |
| Total Accrued Expenses | 16.95% | 12.20% | 2.39% | -12.89% | -29.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.32% | 3.43% | 6.32% | 7.46% | 8.13% |
| Total Finance Division Other Current Liabilities | 13.39% | 46.78% | 23.89% | 423.52% | 193.65% |
| Total Other Current Liabilities | 13.39% | 46.78% | 23.89% | 423.52% | 193.65% |
| Total Current Liabilities | 18.50% | 27.34% | 14.10% | 69.88% | 32.45% |
|
|
|||||
| Total Current Liabilities | 18.50% | 27.34% | 14.10% | 69.88% | 32.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.63% | -9.38% | -9.06% | -8.84% | -8.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -64.58% | -62.97% | -61.98% | -61.05% | 10.01% |
| Total Liabilities | 175.82% | 183.82% | 170.45% | 10.80% | 4.06% |
|
|
|||||
| Common Stock & APIC | 5.56% | 14.49% | 16.83% | 17.24% | 14.43% |
| Retained Earnings | -25.10% | -26.37% | -37.85% | -42.58% | -36.75% |
| Treasury Stock & Other | -387.11% | -217.84% | -149.13% | 167.77% | -53.10% |
| Total Common Equity | -13.98% | 2.07% | -0.80% | -0.53% | -1.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.98% | 2.07% | -0.80% | -0.53% | -1.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.98% | 2.07% | -0.80% | -0.53% | -1.22% |
|
|
|||||